Lavipharm develops, manufactures, markets, and distributes pharmaceutical, cosmetic, and consumer health products. The Company offers pharmaceutical products for cardiology, chronic pain and oncology, central nervous system, general medicine, gastrointestinal system, and urology. It also provides transdermal drug delivery systems (TDDS) related to pain management, hypertension, angina pectoris, Parkinson's disease, asthma, female or male hormone replacement therapy, contraception, nausea, and incontinence.